Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Evogene Ltd. (Nasdaq, TASE: EVGN)

Evogene (NASDAQ, TASE: EVGN) is a leading biotechnology company developing novel products for major life science markets through the use of a unique computational predictive biology (CPB) platform incorporating deep scientific understandings and advanced computational technologies. Today, this platform is utilized by the Company to discover and develop innovative products in the following areas (via subsidiaries or divisions): ag-chemicals, ag-biologicals, seed traits, integrated castor oil ag-solutions, human microbiome based therapeutics and medical cannabis. Each subsidiary or division establishes its product pipeline and go-to-market, as demonstrated in its collaborations with world-leading companies such as BASF, Corteva, Bayer and ICL. *


Period Start 2002-01-01 splitoff
  Predecessor Compugen Ltd. (Nasdaq: CGEN)
Product Industry plant genomics
Person Person Haviv, Ofer (Evogene 200607 CEO)
Region Region Rehovot
  Country Israel
  Street 13 Gad Feinstein st.
Park Rehovot, P.O. Box 2100
  City 76121 Rehovot
  Tel +972-8-931-1900
    Address record changed: 2020-12-02
Basic data Employees n. a.
  Currency USD
  Annual sales 17,581,000 (revenues, consolidated (2013) 2013-12-31)
  Profit -8,878,000 (2013-12-31)
  Cash 95,454,000 (2013-12-31)
    * Document for �About Section�: Evogene Ltd.. (7/15/19). "Press Release: Evogene to Present at Jefferies 2019 Industrials Conference". Rehovot.
Record changed: 2019-07-23


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Evogene Ltd. (Nasdaq, TASE: EVGN)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top